
Agata M Bogusz MD
Hematopathology, Molecular Genetics, Anatomic Pathology
Physician
Join to View Full Profile
3400 Spruce St6.036 GatesPhiladelphia, PA 19104
Phone+1 215-615-6510
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Agata Bogusz, MD is a board certified pathologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania, New Jersey, and Massachusetts.
Education & Training
- Yale-New Haven Medical CenterFellowship, Molecular Genetic Pathology, 2012 - 2013
- Beth Israel Deaconess Medical CenterFellowship, Hematopathology, 2011 - 2012
- University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 2006 - 2009
- RWTH Aachen University FOMClass of 1999
Certifications & Licensure
- PA State Medical License 2013 - 2026
- NJ State Medical License 2018 - 2023
- MA State Medical License 2009 - 2014
- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 2 citationsInduction of Transcriptional Inhibitor HES1 and the Related Repression of Tumor-Suppressor TXNIP Are Important Components of Cell-Transformation Program Imposed by Onc...Qian Zhang, Hong Y Wang, Anindita Nayak, Selene Nunez-Cruz, Artur Slupianek
The American Journal of Pathology. 2022-08-01 - 23 citationsTransdifferentiation of lymphoma into sarcoma associated with profound reprogramming of the epigenome.Qian Zhang, Elena Orlando, Hong Y. Wang, Agata M. Bogusz, Xiaobin Liu
Blood. 2020-10-22 - 33 citationsBrentuximab vedotin in combination with rituximab, cyclophosphamide, doxorubicin, and prednisone as frontline treatment for patients with CD30-positive B-cell lymphomasJakub Svoboda, Steven M. Bair, Daniel J. Landsburg, Sunita D. Nasta, Sarah J. Nagle
Haematologica. 2020-05-15